Richmond Times-Dispatch4d
Petersburg drugmaker Civica misses target for selling cheap insulin
The plant will make three types of insulin, which Civica has pledged to sell for $30 a vial and $55 for a box of five pens.
pharmaphorum2d
Civica plans shake-up of insulin sector with low-cost biosimilars
The biosimilars – which will be interchangeable with Sanofi's Lantus (insulin glargine ... prices of the originator insulin are around $329 per vial and $510 for five pens, according to ...
Medscape2d
Room-temperature Storage of Medications Labeled for Refrigeration
28 days Prescribing information Insulin glargine (rDNA origin) vial or cartridge Lantus vial or cartridge (Sanofi-Aventis) 28 days Prescribing information 70% insulin aspart protamine suspension ...
pharmaphorum6d
Sanofi turns the tables on Lilly with biosimilar fast-acting insulin
But it looks unlikely that Lilly will be able to maintain this with the launch of Humalog, which is available in vial ... acting insulin market with a cheaper version of Sanofi’s Lantus (insulin ...
What consumers should know about the FTC’s upcoming lawsuit against CVS over how it negotiates drug prices
A vial of insulin costs about $8 to manufacture, researchers estimate. But Sanofi’s Lantus costs $292 per vial, Nordisk’s ...